CTRI/2023/05/052211尚未招募Unknown
COMPARATIVE EVALUATION BETWEEN PLATELET RICH PLASMA (PRP) AND PIEZOCISION ASSISTED RATE OF RETRACTION IN BIMAXILLARY PROTRUSION CASES - A CLINICAL STUDY
DR POOJA SHARMA0 个研究点目标入组 0 人开始时间: 待定最近更新:
试验速览
- 阶段
- Unknown
- 状态
- 尚未招募
- 发起方
研究概览
简要总结
暂无简介。
研究设计
- 研究类型
- Interventional
入排标准
入选标准
- •1.Angleâ??s class I malocclusion indicated for bilateral maxillary first premolar extraction.
- •2.Male and female patients between the age group of 18 and 45 years.
- •3.Patients with no clinical signs of periodontal diseases.
- •4.Patients with no gingivitis or untreated caries
- •5.Patients with no history of periodontal therapy.
排除标准
- •1.Previous history of any orthodontic or orthopedic treatment
- •2.Any bone pathology, ankylosed teeth.
- •3.Patients taking drugs modifying normal bone physiology (i.e., bisphosphonates) on or before a period of 3 months.
- •4.Long term use ofanti-biotics, phenytoin, cyclosporine, anti-inflammatory drugs, systemic corticosteroids and calcium channel blockers.
- •6.Patients with evidence of bone loss.
- •7.Patient having a pacemaker or any other active implant.
- •8.Patients who have undergone periodontal treatment within three months of baseline examination.
- •9.Systemic disorder that could influence periodontal health.
研究者
相似试验
尚未招募
不适用
PLATELET RICH PLASMADRESSING VS SALINE DRESSING IN CHRONIC DIABETIC FOOT ULCERSCTRI/2022/04/041557Ashwin Cyril Emperor E
已完成
1 期
COMPARISON BETWEEN GROWTH FACTOR AND BARRIER MEMBRANE WITH SYBOGRAF BONE GRAFT TO SEE BONE FORMATION IN BONE LOSS DISEASESCTRI/2020/12/029845SHARIKA GOPINATH30
尚未招募
不适用
Comparison of two different platelet concentrates mixed with bone graft in the treatment of bone loss at the furcation area of the teethCTRI/2019/09/021471Institute of Dental Studies and Technologies
尚未招募
3 期
COMPARE THE EFFECTIVENESS OF THREE PLATELET RICH PLASMA INJECTIONS GIVEN IN KNEE IN OSTEOARTHRITIS OF KNEE AT AN INTERVAL OF 4 DAYS VS 14 DAYSCTRI/2023/10/058623AIIMS Bhubaneswar
已完成
不适用
COMPARISON OF THE TREATMENTOUTCOMES ON GUM DISEASE WITH THE USE OF PERIOGENâ?¢ AND BLOOD COMPONENTCTRI/2019/02/017391SAIRA SABA15
